BRAF and melanoma: Consistent with this, murine cells derived from a genetically engineered mouse model of melanoma driven by mutant BRAF-V600E and PTEN deletion [17] were sensitive to SCH984 (IC50 0.15 μM; Amax: −73.6%) (Figure S3A-B).